Skip to main content
. 2018 Mar 30;2018(3):CD001021. doi: 10.1002/14651858.CD001021.pub3

5.2. Analysis.

Comparison 5 Inhaled aztreonam lysine (AZLI) versus tobramycin for inhalation solution (TIS), Outcome 2 FEV1 % predicted ‐ mean actual change from baseline.